These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7691974)

  • 1. Experimental pneumonia produced by clinical isolates of Pseudomonas cepacia in mice.
    Yamagishi Y; Fujita J; Takigawa K; Miyawaki H; Takahara J; Yamadori I; Negayama K; Fujimaki K; Nakazawa T
    Kansenshogaku Zasshi; 1993 Sep; 67(9):816-22. PubMed ID: 7691974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of lung infections caused by Pseudomonas aeruginosa in mice treated with cyclophosphamide.
    Mayer P; Walzl H
    Infection; 1983; 11(2):87-96. PubMed ID: 6408008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of the controlled model of persisting infection , caused by Pseudomonas aeruginosa and bacteria of the complex Burkholderia cepacia].
    Chernukha MIu; Kovtun VP; Nikolaeva TN; Shaginian IA; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):14-20. PubMed ID: 15188552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia.
    Starke JR; Edwards MS; Langston C; Baker CJ
    Pediatr Res; 1987 Dec; 22(6):698-702. PubMed ID: 3431954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of bacteria of the Burkholderia cepacia and Pseudomonas aeruginosa complex on cell-mediated immune reactions in experimental animals].
    Chernukha MIu; Nikolaeva TN; Shaginian IA; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):53-7. PubMed ID: 16028514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.
    Speert DP; Bond M; Woodman RC; Curnutte JT
    J Infect Dis; 1994 Dec; 170(6):1524-31. PubMed ID: 7527826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection due to Pseudomonas cepacia.
    Cohen MS; Knowles MR; Yankaskas JR
    Clin Infect Dis; 1993 Aug; 17(2):291-2. PubMed ID: 7691195
    [No Abstract]   [Full Text] [Related]  

  • 8. Colonization and clearance of environmental microbial agents upon intranasal exposure of strain C3H/HeJ mice.
    George SE; Nelson GM; Kohan MJ; Brooks LR; Boyd C
    J Toxicol Environ Health A; 1999 Mar; 56(6):419-31. PubMed ID: 10096364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nosocomial respiratory infection caused by Pseudomonas cepacia in immunocompromised hosts].
    Fujita J; Negayama K; Takigawa K; Kubo A; Yamaji Y; Fujita T; Yamagishi Y; Hata Y; Shiotani T; Takahara J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jul; 30(7):1215-21. PubMed ID: 1383585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.
    Snell GI; de Hoyos A; Krajden M; Winton T; Maurer JR
    Chest; 1993 Feb; 103(2):466-71. PubMed ID: 7679347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired bacteremic Pseudomonas cepacia pneumonia in an immunocompetent host.
    Pujol M; Corbella X; Carratala J; Gudiol F
    Clin Infect Dis; 1992 Nov; 15(5):887-8. PubMed ID: 1280168
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients.
    Yamagishi Y; Fujita J; Takigawa K; Negayama K; Nakazawa T; Takahara J
    Chest; 1993 Jun; 103(6):1706-9. PubMed ID: 7691480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence factors of Burkholderia cepacia.
    Nelson JW; Butler SL; Krieg D; Govan JR
    FEMS Immunol Med Microbiol; 1994 Feb; 8(2):89-97. PubMed ID: 7513590
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
    Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
    Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and environmental isolates of Burkholderia cepacia exhibit differential cytotoxicity towards macrophages and mast cells.
    Melnikov A; Zaborina O; Dhiman N; Prabhakar BS; Chakrabarty AM; Hendrickson W
    Mol Microbiol; 2000 Jun; 36(6):1481-93. PubMed ID: 10931297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia.
    Dale DC; Reynolds HY; Pennington JE; Elin RJ; Pitts TW; Graw RG
    J Clin Invest; 1974 Sep; 54(3):664-71. PubMed ID: 4212040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol inhibits lung clearance of Pseudomonas aeruginosa by a neutrophil and nitric oxide-dependent mechanism, in vivo.
    Greenberg SS; Zhao X; Hua L; Wang JF; Nelson S; Ouyang J
    Alcohol Clin Exp Res; 1999 Apr; 23(4):735-44. PubMed ID: 10235311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of Pseudomonas aeruginosa infection in mice with trichinellosis].
    Bany J; Pfeffer M; Golińska Z; Zdanowska D
    Wiad Parazytol; 2001; 47(4):667-74. PubMed ID: 16886408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.